Education
About Us
Working with TipRanks
Follow Us
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
Total Valuation
Champions Oncology has a market cap or net worth of $114.44M. The enterprise value is $82.78M.
Market Cap$114.44M
Enterprise Value$82.78M
Share Statistics
Champions Oncology has 13,788,421 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,788,421
Owned by Insiders14.24%
Owned by Institutions33.16%
Financial Efficiency
Champions Oncology’s return on equity (ROE) is 1.25 and return on invested capital (ROIC) is 46.44%.
Return on Equity (ROE)1.25
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)46.44%
Return on Capital Employed (ROCE)0.54
Revenue Per Employee271.16K
Profits Per Employee22.39K
Employee Count210
Asset Turnover1.76
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Champions Oncology is 41.5. Champions Oncology’s PEG ratio is -0.13.
PE Ratio41.5
PS Ratio1.72
PB Ratio25.89
Price to Fair Value25.89
Price to FCF13.96
Price to Operating Cash Flow12.52
PEG Ratio-0.13
Income Statement
In the last 12 months, Champions Oncology had revenue of 56.94M and earned 4.70M in profits. Earnings per share was 0.34.
Revenue56.94M
Gross Profit28.55M
Operating Income4.55M
Pretax Income4.63M
Net Income4.70M
EBITDA6.49M
Earnings Per Share (EPS)0.34
Cash Flow
In the last 12 months, operating cash flow was 7.67M and capital expenditures -435.00K, giving a free cash flow of 7.24M billion.
Operating Cash Flow7.67M
Free Cash Flow7.24M
Free Cash Flow per Share0.53
Dividends & Yields
Champions Oncology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.32
52-Week Price Change62.85%
50-Day Moving Average7.04
200-Day Moving Average7.90
Relative Strength Index (RSI)44.44
Average Volume (3m)30.67K
Important Dates
Champions Oncology upcoming earnings date is Dec 16, 2025, After Close (Confirmed).
Last Earnings DateSep 15, 2025
Next Earnings DateDec 16, 2025
Ex-Dividend Date―
Financial Position
Champions Oncology as a current ratio of 0.94, with Debt / Equity ratio of 163.91%
Current Ratio0.94
Quick Ratio0.94
Debt to Market Cap0.00
Net Debt to EBITDA-0.57
Interest Coverage Ratio168.63
Taxes
In the past 12 months, Champions Oncology has paid -75.00K in taxes.
Income Tax-75.00K
Effective Tax Rate-0.02
Enterprise Valuation
Champions Oncology EV to EBITDA ratio is 14.49, with an EV/FCF ratio of 13.43.
EV to Sales1.65
EV to EBITDA14.49
EV to Free Cash Flow13.43
EV to Operating Cash Flow12.73
Balance Sheet
Champions Oncology has $10.32M in cash and marketable securities with $5.75M in debt, giving a net cash position of $4.58M billion.
Cash & Marketable Securities$10.32M
Total Debt$5.75M
Net Cash$4.58M
Net Cash Per Share$0.33
Tangible Book Value Per Share$0.25
Margins
Gross margin is 32.48%, with operating margin of 8.00%, and net profit margin of 8.26%.
Gross Margin32.48%
Operating Margin8.00%
Pretax Margin8.12%
Net Profit Margin8.26%
EBITDA Margin11.39%
EBIT Margin8.51%
Analyst Forecast
The average price target for Champions Oncology is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside72.17% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast10.11%
EPS Growth Forecast―